Skip to main content

Table 3 Summary of the studies on VRE carried out in hospitals in the Dutch-German cross-border region (2012–2018)

From: Vancomycin-resistant enterococci (VRE) in hospital settings across European borders: a scoping review comparing the epidemiology in the Netherlands and Germany

Study

Design

Year

Setting

Patient population

Sample site

Clinical relevance

Species

Sample size

Outcome

Resistance gene (%)

Studies reporting on the prevalence of VRE colonization

Zhou et al. [63]

Cross-sectional

2012–2013

2 university hospitals

ICU, wards

Rectal

Colonization

ND

NL: 445, DE: 102 isolates

VRE isolates: NL, 6; DE, 4 prevalence: NL, 1.3%; DE, 3.9%

NL: vanB (100%), DE: vanB (75%)

Glasner et al. [64]

Cross-sectional

2017–2018

8 Dutch, 15 German hospitals

ICU

Rectal

Colonization

E. faecium

NL: 1110, DE: 2035 isolates

VRE isolates: NL, 1; DE, 55 prevalence: NL, 0.1%; DE, 2.7%

ND

  1. VRE isolates: number of detected isolates of VRE, patients: number of patients diagnosed with VRE
  2. ICU: intensive care unit, ND: not determined, DE: Germany, NL: the Netherlands